Literature DB >> 20091693

Proliferative activity and diagnostic delay in oral cancer.

Juan Seoane1, Salvador Pita-Fernández, Iria Gómez, Inés Vazquez, José Luis López-Cedrún, Domingo De Agustin, Pablo Varela-Centelles.   

Abstract

BACKGROUND: Tumor stage may relate to the chronology of neoplasm growth and has been used as an outcome variable when studying diagnostic delay in oral cancer. However, tumor growth rate may act as a confounding factor.
METHODS: We reviewed a total of 63 incident cases of oral cancer. The variables considered for the study included age, sex, smoking history, tumor site, TNM stage, Ki-67 score, and diagnostic delay.
RESULTS: Significant differences between survivors and exitus were found in terms of tumor stage at diagnosis (I-II vs III-IV), sex, and Ki-67 scores. When the analysis was adjusted for tumor stage at diagnosis (I-II vs III-IV), proliferative activity resulted to be an independent prognostic factor for survival, whereas diagnostic delay did not influence survival.
CONCLUSION: These results seem to suggest that survival from oral cancer is affected more by the biology of the cancer (rapid tumor growth) than by diagnostic delay.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20091693     DOI: 10.1002/hed.21338

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  7 in total

1.  Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany.

Authors:  Katrin Hertrampf; Jörg Wiltfang; Alexander Katalinic; Olaf Timm; Hans-Jürgen Wenz
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-14       Impact factor: 4.553

2.  GLIMMPSE: Online Power Computation for Linear Models with and without a Baseline Covariate.

Authors:  Sarah M Kreidler; Keith E Muller; Gary K Grunwald; Brandy M Ringham; Zacchary T Coker-Dukowitz; Uttara R Sakhadeo; Anna E Barón; Deborah H Glueck
Journal:  J Stat Softw       Date:  2013-09       Impact factor: 6.440

3.  Multilevel Approaches to Reducing Diagnostic and Treatment Delay in Colorectal Cancer.

Authors:  Sherri Sheinfeld Gorin
Journal:  Ann Fam Med       Date:  2019-09       Impact factor: 5.166

4.  Factors related to late stage diagnosis of oral squamous cell carcinoma.

Authors:  Juan-Manuel Seoane-Romero; Inés Vázquez-Mahía; Juan Seoane; Pablo Varela-Centelles; Inmaculada Tomás; José-Luis López-Cedrún
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-01-01

Review 5.  Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.

Authors:  R D Neal; P Tharmanathan; B France; N U Din; S Cotton; J Fallon-Ferguson; W Hamilton; A Hendry; M Hendry; R Lewis; U Macleod; E D Mitchell; M Pickett; T Rai; K Shaw; N Stuart; M L Tørring; C Wilkinson; B Williams; N Williams; J Emery
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

6.  Association between hospital interval and survival in patients with oral cancer: A waiting time paradox.

Authors:  José Luis Lopez-Cedrún; Ana Otero-Rico; Inés Vázquez-Mahía; Juan Seoane; Lucía García-Caballero; Juan Manuel Seoane-Romero; Pablo Varela-Centelles
Journal:  PLoS One       Date:  2019-10-25       Impact factor: 3.240

Review 7.  Time-to-Treatment in Oral Cancer: Causes and Implications for Survival.

Authors:  Constanza Saka-Herrán; Enric Jané-Salas; Antoni Mari-Roig; Albert Estrugo-Devesa; José López-López
Journal:  Cancers (Basel)       Date:  2021-03-16       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.